Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Nervous system conditions and treatments
Home
Nervous system conditions and treatments
Nervous system conditions and treatments
Type here to filter the list
(188) Association between antidepressants and risk of withdrawal syndrome in illicit substance users: nationwide case-case-time-control study
Favorite
(189) Disability and Workers’ Compensation Absences Associated with Major Depressive Disorder and the Overlap with Family Medical Leaves Among US Employees
Favorite
(190) Do efficacy results obtained from randomised controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
Favorite
(191) Healthcare resource use (HRU) of patients with active relapsing multiple sclerosis (RMS) using data linkage between a phase IV study and the France's national health data system.
Favorite
(192) Impact of the disability status of patients with multiple sclerosis on healthcare resource utilization and the ability to work: An analysis of the MSDS-AOK PLUS Linked Database
Favorite
(193) Inflammatory Bowel Disease among Patients with Multiple Sclerosis and matched Controls: Findings from a Retrospective Cohort Study Utilizing a US Electronic Health Record Database
Favorite
(194) Risk Of Cardiovascular Events Among Youths And Young Adults With Concomitant Use Of Atypical Antipsychotics With Antidepressants
Favorite
(195) Systematic emulation trials to evaluate the real-world effectiveness of multiple sclerosis treatments
Favorite
(196) The relative risk of infection in people with multiple sclerosis using disease-modifying treatments: a systematic review of observational studies
Favorite
(197) The Risk of Hypokalemia in Patients Treated with Levetiracetam: A Comparative Cohort Study
Favorite
(210) Adjunctive treatments for depression: Delineating real-world treatment patterns
Favorite
(211) Agomelatine and Inverse Risk of Hypertension, Diabetes and Hyperlipidemia: A Nationwide Active-comparator Study
Favorite
(212) An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of methylphenidate and potential signal for obsessive-compulsive disorders
Favorite
(213) An Assessment of Use and Emerging Safety of Esketamine Nasal Spray in the U.S., 2019-2023
Favorite
(214) Characteristics and drug utilization patterns of patients with migraine initiating erenumab in Nordic countries
Favorite
(215) Concurrent Use of Prescription Benzodiazepines and Cannabis in Prevalent Medical Cannabis Users with Mental Health Conditions: A Cross-Sectional Survey
Favorite
(216) Deprescribing of antidepressants: Development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method
Favorite
(217) Effectiveness of low-dose amitriptyline and mirtazapine in insomnia disorder: a randomised, double-blind, placebo-controlled trial in general practice (the DREAMING study)
Favorite
(218) Estimation of Daily Delta-9-Tetrahydrocannabinol Doses Among Participants in Florida's Medical Marijuana Use Registry: A Study on Trends and Patterns in Medical Cannabis Utilization
Favorite
(219) Identification of migraine in electronic healthcare data sources: a headache for pharmacoepidemiologists – a systematic literature review
Favorite
(220) Impact of deregulation of the Brazilian National Controlled Products Management System on antidepressants’ sales data
Favorite
(221) Incidence of moderate and profound hyponatremia during treatment with selective serotonin reuptake inhibitors (SSRIs) – evidence from the Stockholm Sodium Cohort (SSC).
Favorite
(222) Medically-attended cannabis-related disorders among U.S. Medicare beneficiaries, 2017–2022
Favorite
(223) Modeling Medical, Prescription, Disability, and Absence Costs for Employees with Major Depressive Disorder (MDD): Using Shorter Pre-Index Time Periods for Charlson Comorbidity Indexes (CCI) and Smaller Sample Sizes
Favorite
(224) Patient characteristics associated with new community prescription of benzodiazepine and z-drug hypnotics after critical illness in the UK, a retrospective cohort study.
Favorite
(225) Peyronie´s disease and risk of depression. A nationwide 25-year cohort study
Favorite
(226) Prevalence and sociodemographic characteristics of people with prescription stimulant use disorder: results from the National Survey on Drug Use and Health, 2015-2019
Favorite
(227) Risk assessment of decreased platelet count in patients prescribed antidepressants using the MID-NET in Japan
Favorite
(228) Trends of Triptans Use in Hungary
Favorite
(298) A nationwide study of psychotherapy treatment at Danish psychiatric clinics
Favorite
(299) An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of paliperidone, risperidone, and low-energy fracture
Favorite
(300) Antipsychotics in treatment of adolescents with schizophrenia in China
Favorite
(301) Anxiety Disorders Diagnosed in Outpatient Encounters Among Commercially Insured US Adults
Favorite
(302) Assessment of Polypharmacy And Potentially Inappropriate Medication Use Among Psychiatric Patients: A Prospective Study.
Favorite
(303) Benzodiazepine receptor agonists and increased risk of sudden sensorineural hearing loss
Favorite
(304) Brain derived Neurotrophic factor (BDNF): A potential biomarker for seizure associated cognitive impairment in adult persons with epilepsy (PWE)
Favorite
(305) Daridorexant and sleeping disorders: comparative study with sleeping medication (zopiclone, oxazepam).
Favorite
(306) Development of matching procedures to identify comparators for real-world comparative evaluations of antipsychotics
Favorite
(307) Efficacy and safety of riluzole in the treatment of Amyotrophic Lateral Sclerosis, a population based study in Italy
Favorite
(308) Evaluation Epilepsy Patterns and Treatment Approaches: Findings from a Neurological Tertiary Care Hospital
Favorite
(309) Examining the impact of benzodiazepine formulary restrictions on benzodiazepine-related harms in a Medicaid population, 2004-2016
Favorite
(310) Fatal intoxications with zopiclone and alprazolam in Sweden during 2012-2020 – a register-based study
Favorite
(311) Generalized anxiety disorder: Epidemiology, burden, and comorbid depression.
Favorite
(312) Identifying Longitudinal Medication Adherence Patterns of Antipsychotic Treatments; A Real-World Cohort Study in Catalonia, Spain.
Favorite
(313) Influence of unemployment on antidepressant sales in drugstores in Brazil: time series analysis, 2014-2021
Favorite
(314) Mapping the Epidemiological burden of active and lifetime epilepsy in Asian Countries: A Systematic review and Meta-analysis
Favorite
(315) Post-discharge Use of Antipsychotics in Patients with Hospital-acquired Delirium and Associated Risk of Mortality – A Target Trial Emulation Framework Study
Favorite
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Favorite
(317) Psychotropic medicine use in the German National Cohort (NAKO) baseline
Favorite
(318) Safety and efficacy of second-generation antipsychotics in Autism Spectrum Disorder: a systematic review and network meta-analysis
Favorite
(319) The risk of myocarditis, cardiomyopathy and cutaneous vasculitis associated with quetiapine in patients with schizophrenia and bipolar disorder.
Favorite
(320) Therapeutic strategies after discontinuation of valproate in clinical practice in women with bipolar disorder: a cohort study in the United Kingdom and France databases
Favorite
(321) Therapeutic strategies after discontinuation of valproate in clinical practice in women with epilepsy: a cohort study in the United Kingdom and France databases
Favorite
(322) Trends in gabapentinoid prescribing: a nationwide Danish drug utilization study
Favorite
(323) Trends In Psychotropic Medication Utilisation in Community Pharmacies In Chile Between 2018 - 2022
Favorite
(324) Utilization of Antiparkinsonian Medication in Romania over 25 years
Favorite
(325) Utilization of Psychotropic Medications Among Patients Diagnosed with Glioma: A Multinational Drug Utilisation Study
Favorite
